News

Everi Holdings Celebrates Stock Surge, Reaches New Heights

Everi Holdings Celebrates Stock Surge, Reaches New Heights

Everi Holdings Achieves New Milestone in Stock Performance

Everi Holdings, known as EVRI, has marked a significant accomplishment by reaching a new 52-week high with its stock price climbing to $13.39. This impressive figure highlights a remarkable period of growth for the company, with a notable stock value increase of 23.61% over the past year. Investors have demonstrated a stronger belief in Everi's position within the market and its future developments, contributing to this stock performance surpassing earlier expectations.

Recent Changes and Analyst Ratings

In the wake of this achievement, Everi Holdings has experienced several updates in stock ratings and analysts' perspectives. B.Riley maintained a Neutral rating on the stock, adjusting its EBITDA estimates for upcoming years due to anticipated delays related to product transitions and the merger with International Game Technology (IGT). B.Riley expects the company to achieve positive EBITDA growth by the fourth quarter of the following year, partly attributed to Everi's entry into the Video Lottery Terminal market.

Responses from Analysts

Stifel has taken a more cautious approach by downgrading Everi from a Buy to a Hold recommendation, while raising its price target to $14.25. The firm expressed optimism regarding the forthcoming acquisition by Apollo Global Management and stated that the deal is anticipated to yield beneficial returns for shareholders, thanks to the secured financing commitments by Apollo.

Market Expectations Post Acquisition

Raymond James recalibrated its outlook on Everi Holdings, moving its rating from 'Strong Buy' to 'Market Perform' as reactions to the acquisition surfaced. The valuation placed on Everi at $14.25 per share aligns closely with expectations from the IGT deal, and the analysts do not foresee a rival offer due to ongoing challenges in the gaming sector.

Performance Insights from Everi's Financials

In the first quarter, Everi reported some fluctuations within its gaming segment, showcasing a decline while its Fintech cash access division experienced growth. The adjusted EBITDA dropped to $80.3 million compared to $92.5 million the previous year. Nevertheless, positive revenue outcomes are expected, with a return to growth anticipated in Fintech revenues during the latter half of the next year.

Analyzing Recent Trends and Insights

Everi's stock performance has resonated well with key performance indicators. The stock achieved an impressive 59.88% price return over six months and a 46.06% return over three months, indicating a strong momentum in its trajectory. Notably, EVRI is trading at 99.93% of its 52-week high, further reinforcing the notion of its significant upward movement.

Profitability and Market Position

Insights reveal that Everi's gross profit margins are noteworthy, as evidenced by a reported gross profit margin of 80.39% for the last twelve months. This strong performance suggests that Everi has effectively maintained operational efficiency even through fluctuating market conditions. Investors should, however, remain cautious as indicators suggest the stock may be experiencing overbought conditions, hinting at the possibility of a short-term pullback.

Frequently Asked Questions

What is Everi Holdings' stock price as of now?

Everi Holdings' stock is presently trading at $13.39, marking a 52-week high.

How has Everi's stock performed over the last year?

The stock has seen a remarkable rise of 23.61% in value over the past year.

What recent changes occurred with Everi's analysts' ratings?

Analysts have revised their ratings with Stifel downgrading to Hold and B.Riley maintaining Neutral, amid merger developments.

What profitability metrics are associated with Everi Holdings?

Everi reported a gross profit margin of 80.39% over the last twelve months, illustrating strong operational efficiency.

What should investors watch for in Everi's performance?

Investors should monitor potential short-term pullback signs due to current overbought conditions while remaining informed on merger impacts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 0

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 249

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading